An international clinical trial reported improved radiotherapy planning performance using AI for cervical and prostate cancer treatment, with investigators from University College London (UCL) and the London School of Hygiene & Tropical Medicine (LSHTM) leading the work. The study described AI used to support treatment planning—aiming to standardize or speed up planning steps involved in delivering life-saving radiotherapy. The emphasis was on applicability for low- and middle-income settings, where radiotherapy expertise and planning resources can be limiting. For the industry, the update reinforces demand for validated AI tooling in regulated clinical workflows, including evidence packages that address performance, safety, and integration into existing radiotherapy operations.